About this trial
The goal of this prospective cohort study is to compare the predictive accuracy of the Revised Trauma Score (RTS) and the MGAP score in determining clinical outcomes among multiple trauma patients hospitalized at a trauma center in Iraq.
The main questions it aims to answer are:
Which score, RTS or MGAP, provides a more accurate prediction of clinical outcomes, including mortality? Are there specific subgroups of trauma patients where one scoring system outperforms the other?
Participants will:
Be assessed using both the RTS and MGAP scores upon admission. Have their clinical outcomes, including mortality and other relevant indicators, monitored throughout their hospital stay.
Eligibility criteria
Qualifiers
Presentation to the trauma center within 6 hours of injury.
Availability of complete clinical and demographic data for scoring using RTS and MGAP.
Patients who consent to participate in the study or whose legal representatives provide consent.
Capability to assess outcomes such as survival, ICU admission, and complications.
Disqualifiers
Patients who expired before scoring or evaluation
Missing or unreliable medical data for RTS or MGAP score calculations.
Transfers from other facilities with interventions that could impact RTS or MGAP reliability.
Pregnant patients, due to the unique considerations of trauma in pregnancy.
Trial design
Treatments tested in this trial
- Not listed